Elena Castro
Elena Castro, MD, PhD
Elena Castro is a Consultant Medical Oncologist in GU tumors at the Virgen de la Victoria University Hospital in Malaga, Spain, where she leads the GU cancers translational research unit as part of the Malaga Biomedical Research Institute (IBIMA). Castro’s research is focused on the clinical and molecular characterization of BRCA2 mutations, and other DNA repair defects in prostate cancer.
Disclosures: Honoraria or consultation fees: AstraZeneca, Bayer, Daiichi Sankyo, Janssen, Lilly, Medscape, Merck, MSD, Novartis, and Pfizer. Grants and research support: Bayer (inst), Janssen (inst), and Pfizer (inst). Speaker fees: Astellas, AstraZeneca, Bayer, Janssen, Novartis, Pfizer, Sandoz, and Telix Pharmaceuticals. Travel support: AstraZeneca, Janssen, and Pfizer.
View content featuring Castro:
This content has been developed independently by Medthority who previously received educational funding from Pfizer in order to help provide its healthcare professional members with access to the highest quality medical and scientific information, education and associated relevant content.